AstraZeneca in $560 m deal for respiratory firm
Jun 10, 2013 | Posted by: roboblogger | Full story: Seattle Times
British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.
Since: Apr 13
This sounds promising.
10 Users are viewing the Biotech Forum right now
|Merck's MSD Pharma to create 800 jobs in India (Nov '08)||Sat||Jitendra Kumar Kushwaha||210|
|Obama announces $100 million initiative at Nati...||Dec 4||rajuarun||1|
|J&J Failed to Warn of Vaginal Mesh Risks, Jury ... (Mar '13)||Dec 2||jacobgabriel001||7|
|Verdict: $3.35 Million Awarded in Vaginal Mesh ... (Mar '13)||Dec 2||jacobgabriel001||3|
|U.S. Stock Futures Rise as Retail Sales Gain Mo... (Mar '13)||Dec 2||The Prudent Investor||5|
|Wockhardt receives Us Fda approval for cardiac ... (Oct '10)||Dec 1||Chitreana||15|
|Lawsuits filed over Lipitor side effects (Jun '06)||Nov 30||Mickey||801|